Proteins / TCEANC2
TCEANC2
Transcription elongation factor A N-terminal and central domain-containing protein 2
Predicted 3D structure
AlphaFold model.
In plain language
TCEANC2 has barely been studied. The model's best guess: A nuclear transcription-elongation regulator that binds RNA polymerase II through a bipartite scaffold and stabilizes elongation complexes without acting as a classical RNA cleavage–re-priming enzyme. It likely operates in the nucleoplasm and nucleolus, where it assembles and remodels transcription assemblies to reduce backtracking and sustain productive RNA synthesis by RNA polymerase II.
A nuclear transcription-elongation regulator that binds RNA polymerase II through a bipartite scaffold and stabilizes elongation complexes without acting as a classical RNA cleavage–re-priming enzyme.
Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.
Protein domains
Known building blocks found by InterPro, placed along the 208 amino acids of the chain. Hover or tap a block for details.
- TFIIS/LEDGF domain superfamily · 37–110
- Transcription elongation factor S-II, central domain superfamily · 111–208
- Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type · 38–113
- Transcription factor IIS, N-terminal · 40–114
- Transcription elongation factor S-II, central domain · 131–208
Predicted function
Model summary
A nuclear transcription-elongation regulator that binds RNA polymerase II through a bipartite scaffold and stabilizes elongation complexes without acting as a classical RNA cleavage–re-priming enzyme. It likely operates in the nucleoplasm and nucleolus, where it assembles and remodels transcription assemblies to reduce backtracking and sustain productive RNA synthesis by RNA polymerase II.
Predicted Gene Ontology terms
Biological process
Which larger process it takes part in
- GO:0006366 transcription by RNA polymerase II
Model reasoning
How the model got to its answer
- 01
I begin with the InterPro architecture.
The N-terminal half is densely annotated by IPR035441 (TFIIS/LEDGF domain superfamily, residues 37–110), IPR003617 (Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type, residues 38–113), and IPR017923 (Transcription factor IIS, N-terminal, residues 40–114). This cluster defines the canonical TFIIS N-terminal module that binds RNA polymerase II and positions the factor on the elongation complex. Immediately downstream, IPR036575 (Transcription elongation factor S-II, central domain superfamily, residues 111–208) and IPR003618 (Transcription elongation factor S-II, central domain, residues 131–208) specify the central TFIIS domain that stabilizes the elongation complex and coordinates with the N-terminal module. The ordered layout—N-terminal TFIIS/LEDGF-like fold followed by the central TFIIS core—creates a bipartite scaffold that binds RNA polymerase II and accessory factors. This architecture causes high-affinity protein–protein interactions central to elongation control, supporting GO:0005515 protein binding as the operative molecular function.
- 02
From this binding-centric architecture, the biological role follows.
TFIIS-family N- and central-domains assemble on arrested or backtracked RNA polymerase II and bias the elongation cycle toward productive RNA synthesis. By stabilizing the elongation complex and coordinating factor exchange, this module drives the process formalized as GO:0006366 transcription by RNA polymerase II. The absence of catalytic motifs and the presence of multiple interaction domains argue that regulation occurs through allosteric remodeling and recruitment rather than enzymatic cleavage.
- 03
Cellular localization is dictated by function and binding partners.
The TFIIS/LEDGF-like N-terminal domain and the central TFIIS core are hallmarks of nuclear elongation factors, placing the protein in the nucleoplasm where active transcription complexes reside, consistent with GO:0005654 nucleoplasm. Transcription elongation factors often transit through nucleolar territories that serve as assembly and storage hubs for RNA biogenesis machinery, aligning with GO:0005730 nucleolus. Together, these features situate the protein in the nucleus with dynamic nucleoplasmic–nucleolar exchange.
- 04
Mechanistically, the N-terminal TFIIS/LEDGF-like region anchors to RNA polymerase II and associated elongation assemblies, while the central domain stabilizes the elongation trajectory and coordinates factor handoff.
This bipartite scaffold likely recruits or competes with other elongation regulators to prevent excessive backtracking and to promote RNA chain extension and transcript release. I hypothesize that it engages RNA polymerase II core subunits and elongation cofactors, transiently forming assemblies with DSIF and NELF to tune pausing and with chromatin-tethering modules to couple elongation to chromatin states. These interactions would allow it to modulate the elongation cycle without acting as a classical RNA cleavage–re-priming enzyme, instead functioning as a recruitment and stabilization hub for productive transcription.
Technical details
InterPro entries
- IPR035441 TFIIS/LEDGF domain superfamily homologous superfamily · 37–110
- IPR036575 Transcription elongation factor S-II, central domain superfamily homologous superfamily · 111–208
- IPR003617 Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type domain · 38–113
- IPR017923 Transcription factor IIS, N-terminal domain · 40–114
- IPR003618 Transcription elongation factor S-II, central domain domain · 131–208
Sources
- Sequence: UniProt Q96MN5
- Structure: AlphaFold DB (PDB file)
- Domains: InterPro
- Dark protein list: Pharos (Tdark)
Method
BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →